Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Science Business Announcements
EurekAlert! provides eligible reporters with free access to embargoed and breaking news releases.
Eligibility GuidelinesEurekAlert! offers eligible public information officers paid access to a reliable news release distribution service.
Eligibility GuidelinesEurekAlert! is a service of the American Association for the Advancement of Science.
The NIH has launched a phase 3 clinical trial to examine the use of prescription and over-the-counter medications for people with mild-to-moderate COVID-19. These individuals are not sick enough to be hospitalized. The trial is part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership. NIH will provide an initial investment of $155 million in funding for the trial, which will be overseen by the National Center for Advancing Translational Sciences.
The UC Davis MIND Institute is now offering online treatment appointments as part of its clinical trial known as the STAAR study. The trial will compare the effectiveness of the medication sertraline and cognitive behavioral therapy in treating anxiety in children with autism.
Woods Hole Oceanographic Institution (WHOI) and Analog Devices, Inc. (Nasdaq: ADI) today launched the Ocean and Climate Innovation Accelerator (OCIA) consortium. ADI has committed $3 million over three years towards the consortium which will focus on advancing knowledge of the ocean's critical role in combatting climate change as well as developing new solutions at the intersection of oceans and climate.
Computer gaming technology is being used to develop and pilot two low cost, next-generation screening tools for 'lazy eye' in children.
The strategic university partnership is aimed at embedding global and social responsibility into education and student experience.
A first participant was dosed at I-Motion, the pediatric clinical trial platform for neuromuscular diseases located at Trousseau hospital in Paris, as part of the gene therapy trial in Duchenne muscular dystrophy (DMD) conducted by Genethon.
Today, the International Osteoporosis Foundation (IOF) & Osteoporosis Canada (OC) announced the inclusion of 42 Fracture Liaison Services (FLS) from the Osteoporosis Canada FLS Registry on the Capture the Fracture® Map of Best Practice. The integration of the Canadian FLS on the Capture the Fracture® global map follows a collaboration agreement in which the two organizations underline their shared goal of improving clinical outcomes and preventing recurrent fractures in patients who have sustained fractures due to osteoporosis.
With an eye on future mobile communications standards, a European consortium is working on the next generation of antennas for wireless networks. Austria is clearly represented with NXP, Technikon and TU Graz.
A hand surgeon at Hospital for Special Surgery performed the first surgery with an FDA-cleared total wrist replacement implant he designed.
A team of Korean and British researchers have successfully performed a demonstration test of AR services on the subway by using the mobile backhaul communication technology that they have jointly developed. The test shows that people will soon be able to enjoy a wide range of high quality multimedia services including high-definition video streaming in a mobile environment such as buses and subway.